LekoskopLekoskop
UK · ES · FR · CS · IT · NL · CH · HR · PL

Medicine recalls, shortages and safety updates in the UK — March 2026

MHRA medicines recalls and defect notifications with batch numbers, Serious Shortage Protocols, new approvals and Drug Safety Update — updated daily, automatically. Last updated: 27 Sep 2026 13:39.

All Recalls and defects2 Serious shortages (SSP)2 New approvals1 Drug Safety Update1
clear

Sources: we track changes based on information published by the MHRA — medicines recalls and defect notifications, Drug Safety Update and approval announcements — and the Serious Shortage Protocols published by the NHS Business Services Authority. The UK is outside the EU, so European Commission decisions are not listed here.

expand all dayscollapse all days

30 Mar 2026Monday 30 March 2026

open day ◀ ▶ 1 event · 1 important
Medicines recall Rabies, Human normal Immunoglobulin 500IU solution for Injection
Class 2 recall · DMRC- 38515822 · PL: 08801/0014 · Bio Products Laboratory Limited · Human Rabies Immunoglobulin
What this means, batches, details

Loading…

MHRA alert on GOV.UK ↗ MHRA — Medicines and Healthcare products Regulatory Agency

26 Mar 2026Thursday 26 March 2026

open day ◀ ▶ 2 events
Medicines recall Vesomni 6 mg/0.4 mg modified release tablets
Class 4 defect notification · DMRC-38793027 · Quadrant Pharmaceuticals Limited · solifenacin succinate, tamsulosin hydrochloride
Batches: 4097Y (31/12/2026), 4105Y (30/09/2026), 4322Y (31/12/2026), 5386Y (31/12/2026), 7330Y (31/12/2026), 7347Y (30/04/2027)
What this means, batches, details

Loading…

MHRA alert on GOV.UK ↗ MHRA — Medicines and Healthcare products Regulatory Agency
Medicines recall Apixaban 5mg Tablets
Class 4 defect notification · 2 products · DMRC-38614094 · PL: 04416/1608 · Sandoz Limited · apixaban
Batches: PS2891 (30/06/2028), PT0565 (30/06/2028), PT1417 (31/07/2028), PU0476 (31/07/2028), PU0481 (31/08/2028), PV5375 (31/07/2028), PW1623 (31/07/2028), PW1624 (30/04/2028), PU1963 (31/07/2028), PU3287 (31/01/2028), PT4596 (31/07/2028), PT2868 (31/07/2028), PU2604 (31/07/2028), PU2605 (31/07/2028), PU2606 (31/07/2028), PT1722 (30/11/2027)
What this means, batches, details

Loading…

MHRA alert on GOV.UK ↗ MHRA — Medicines and Healthcare products Regulatory Agency

23 Mar 2026Monday 23 March 2026

open day ◀ ▶ 1 event · 1 important
Medicines recall Hibiwash 500ml
Class 2 recall · DMRC- 38814497 · PL: 22099/0003 · Regent Medical Limited / Mölnlycke Health Care · chlorhexidine gluconate 4%
Batches: 5156042 (28/11/2028), 500ml (10/02/2026), 5156043 (28/11/2028), 5156093 (28/11/2028), 500ml (10/03/2026)
What this means, batches, details

Loading…

MHRA alert on GOV.UK ↗ MHRA — Medicines and Healthcare products Regulatory Agency

17 Mar 2026Tuesday 17 March 2026

open day ◀ ▶ 1 event
Medicines recall Onkotrone Injection 2mg/ml concentrate for solution for infusion in 10 ml vials
Class 4 defect notification · DMRC-38016571 · PL: 00116/0398 · Baxter Healthcare Corporation · mitoxantrone hydrochloride
What this means, batches, details

Loading…

MHRA alert on GOV.UK ↗ MHRA — Medicines and Healthcare products Regulatory Agency

12 Mar 2026Thursday 12 March 2026

open day ◀ ▶ 3 events · 2 important
Medicines recall Gastrografin gastroenteral solution
Class 3 recall · 3 products · DMRC- 38673150 · PL: 00010/0537 · Bayer Plc · meglumine amidotrizoate and sodium amidotrizoate
Batches: MA04HM9 (02/2028), 10x100ml (01/05/2024), MA04JKA (03/2028), 10x100ml (31/05/2024), MA04KFC (04/2028), 10x100ml (30/07/2024), MA04KJ9 (04/2028), 10x100ml (01/08/2024), MA04M60 (07/2028), 10x100ml (23/09/2024), MA04MLL (08/2028), 10x100ml (04/11/2024), MA04MM9 (09/2028), 10x100ml (15/12/2024), MA04MN9 (09/2028), 10x100ml (19/01/2025), MA04NDU (10/2028), 10x100ml (13/02/2025), MA04NNB (11/2028), 10x100ml (06/03/2025), MA04PJL (12/2028), 10x100ml (15/04/2025), MA04PLZ (12/2028), 10x100ml (29/05/2025), MA04PMV (01/2029), 10x100ml (11/07/2025), MA04RL2 (02/2029), 10x100ml (14/08/2025), MA04RL3 (02/2029), 10x100ml (15/09/2025), MA04S6C (02/2029), 10x100ml (30/10/2025), MA04S6B (02/2029), 10x100ml (03/10/2025), MA04S6T (02/2029), 10x100ml (02/12/2025), MA04XJ8 (07/2029), 10x100ml (09/01/2026), MA044UD (03/2026), 1x250ml (09/02/2023), MA04A58 (03/2026), 1x250ml (27/06/2023), MA04BVD (07/2026), 1x250ml (09/11/2023), MA04BVE (07/2026), 1x250ml (23/01/2024), MA04HS8 (02/2029), 1x250ml (04/06/2024
What this means, batches, details

Loading…

MHRA alert on GOV.UK ↗ MHRA — Medicines and Healthcare products Regulatory Agency
Medicines recall Curaleaf Oil [FS] 10mg/ml THC, 10mg/ml CBD (30ml)
Class 2 recall · DMRC- 38668711 · Rokshaw Limited Trading as Curaleaf Laboratories · delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD)
Batches: B11/01/24-30 (28/02/2026), B11/04/24-30 (31/07/2026), B11/05/24-30 (31/07/2026)
What this means, batches, details

Loading…

MHRA alert on GOV.UK ↗ MHRA — Medicines and Healthcare products Regulatory Agency
MHRA approval deuruxolitinib (Leqselvi)
As with any medicine, the MHRA will keep the safety and effectiveness of deuruxolitinib under close review.
What this means, batches, details

Loading…

MHRA announcement ↗ MHRA — Medicines and Healthcare products Regulatory Agency
older days →

In total 9 events this month.